CONNECTIVE TISSUE PATHOLOGY AS A RISK FACTOR FOR INTESTINAL FISTULA DEVELOPMENT (57-61)

Архив в PDF формате
Дата публикации статьи в журнале: 2020/01/08
Название журнала: Восточно Европейский Научный Журнал, Выпуск: 52, Том: 1, Страницы в выпуске: 57-61
Автор: Voitiv Ya. Yu.
Kyiv, Shupyk National Medical Academy of Postgraduate Education, PhD
Автор: Ali Dzhemiliev
, Shalimov National Institute of Surgery and Transplantology ,
Анотация: Retro- and prospective trial was based on data about 30 patients, suffering intestinal fistulas, who were treated in the Shalimov National Institute of Surgery and Transplantology during 2016-2019. There was revealed that the most informative phenotypical markers of undifferentiated dysplasia of the connective tissue (UDCT) in patients with intestinal fistulas are visceral (83,3%), vascular (70%), arrhythmic (70%) pathologies. It is established that a direct correlation between the level of biochemical markers of the collagen biodegradation and the UDCT degree may be applied for prognostication of development and course of complications in patients, suffering entero- colocutaneous fistulas. The presence of connective tissue dysplasia in patients with intestinal fistulas was proved to be the aggravating comorbidity factor, that is difficult to treat and is accompanied by high mortality rates. Severe degree of UDCT in the patients, intestinal fistulas, constitutes unfavorable prognostic sign and enhances the mortality by 62.5%. The presence of UDCT in the patients with intestinal fistulas is an aggravatin comorbid factor that is difficult to be treated and accompanied by high rates of mortality, which must be taken into account, choosing the adequate surgical tactics and complex pathogenetically substantiated treatment.
Ключевые слова: undifferentiated dysplasia of connective tissue   intestinal fistula   phenotypic and biochemical markers   diagnostic criteria   comorbid factor  
Данные для цитирования: Voitiv Ya. Yu. , Ali Dzhemiliev , . CONNECTIVE TISSUE PATHOLOGY AS A RISK FACTOR FOR INTESTINAL FISTULA DEVELOPMENT (57-61). Восточно Европейский Научный Журнал. Медицинские науки. 2020/01/08; 52(1):57-61.

Список литературы: 1. Schecter WP, Hirshberg A, Chang DS, et al. Enteric fistulas: principles of management. J Am Coll Surg. 2009;209:484-91. 2. Teixeira PGR, Inaba K, Dubose J, Salim A, Brown C, Rhee P, et al. Enterocutaneous fistula complicating trauma laparotomy: A major resource burden. Am Surg. 2009;75(1):30–32. 3. Fischer JE. The pathophysiology of enterocutaneous fistulas. World J Surg. 1983;7:446-50.; 4. Surgical treatment—evidence-based and problem-oriented Edited by Rene G. Holzheimer, John A. Mannick, München, Germany: W. Zuckschwerdt Verlag Munchen, 2001. 843 p. 5. Whelan J, Ivatury R. Enterocutaneous fistulas: an overview. Eur J Trauma Emerg Surg. 2011;37(3):251–258. doi: 10.1007/s00068-0110097-2. 6. Williams LJ, Zolfaghari S, Boushey RP. Complications of Enterocutaneous Fistulas and Their Management. Clin Colon Rectal Surg. 2010;23(3):209–220. doi: 10.1055/s-00301263062 . 7. Lloyd D, Gabe S, Windsor A. Nutrition and management of enterocutaneous fistula. Br J Surg.2006;93(9):1045–1055. doi: 10.1002/bjs.5396. 8. Nechaeva HY, Martynov AY. Dysplazyia soedynytelnoi tkany: sovremennye podkhody k dyahnostyke y lechenyiu. Stavropol: MYA; 2017. 399 p. [In Russian]. 9. Usenko OYu, Voitiv Ya.Yu. Chastota ta kryterii diahnostyky nedyferentsiiovanoi dysplazii spoluchnoi tkanyny u khvorykh khirurhichnoho statsionaru. Klinichna khirurhiia. 2017; 10: 5-7. [In Ukrainian]. DOI: https://doi.org/10.26779/25221396.2017.10.05. 10. Patent of Ukraine No. 120158 UA, IPC А61В 8/12 (2017) The method for the diagnosis of undifferentiated dysplasia of the connective tissue / Usenko O.Yu., Voitiv Y.Yu., Shcherbina S.I.; No. u2017 03889; declared 04/20/2017; publ. 10/25/2017, Bull.№20, 2017.